5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)

Nov 25, 2024 · 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) Nov. 25, 2024 3:47 PM ET Bristol-Myers Squibb Company (BMY) Stock , BMYMP Stock PRTC , RPRX …

CouponFollow Extension

14%
OFF

Bristol-Myers Squibb Shares Rise After Analyst Upgrades, Positive ...

3 weeks from now

Dec 16, 2024 · With a new price target of $70, Jefferies sees upside potential in Bristol-Myers Squibb's stock. BMY Price Action: Bristol-Myers Squibb shares were up 0.14% at $55.86 at …

benzinga.com

10%
OFF

Bristol Myers Squibb Clears Key Benchmark, Hitting 80-Plus RS …

3 weeks from now

Nov 20, 2024 · Bristol Myers Squibb showed -10% earnings growth in the latest quarterly report, while sales growth came in at 8%. The company earns the No. 2 rank among its peers in the …

investors.com

$10
OFF

Bristol Myers Stock Screams To A Year-High After Walloping Profit ...

3 weeks from now

Oct 31, 2024 · "With this impact, Bristol has guided toward worldwide Eliquis revenues in the range of $10.5 billion to $12.5 billion in 2026, and $8.5 billion to $11.0 billion in 2027," he said.

investors.com

$64.93
OFF

Bristol-Myers Squibb NYSE:BMY Stock Report - Simply Wall St

3 weeks from now

Current Share Price: US$64.93Beta: 0.6352 Week High: US$69.7552 Week Low: US$53.22

simplywall.st

FAQs about 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) Coupon?

Is Bristol Myers Squibb a good buy right now?

While the stock is not near an ideal buy point right now, see if it goes on to form and break out from a proper consolidation. Bristol Myers Squibb reported -10% EPS growth in its most recent report, while sales growth came in at 8%. Bristol Myers Squibb holds the No. 2 rank among its peers in the Medical-Ethical Drugs industry group. ...

Is Bristol-Myers Squibb a good stock to buy?

Analysts like Bristol-Myers Squibb less than other "medical" companies. The consensus rating for Bristol-Myers Squibb is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BMY compares to other companies. ...

Is B Ristol Myers Squibb a good stock to buy?

B ristol Myers Squibb had its Relative Strength (RS) Rating upgraded from 63 to 79 Tuesday — a welcome improvement, but still shy of the 80 or better score you look for. Please watch the video at Investors.com - Find Top Growth Stocks With The IBD Screen Of The Day ...

What is the price target for Bristol-Myers Squibb (BMY)?

The highest price target for BMY is $73.00, while the lowest price target for BMY is $39.00. The average price target represents a forecasted upside of 0.76% from the current price of $55.84. Enter your email address to receive the latest news and analysts' ratings for Bristol-Myers Squibb and its competitors. ...

When did Bristol-Myers Squibb last update?

They were last updated on Friday, January 3, 2025. Please send any questions or comments about these Bristol-Myers Squibb pros and cons to [email protected]. Recent earnings report showed an EPS of $1.80, exceeding expectations of $1.49, indicating strong financial performance and effective management. ...

Is Bristol-Myers Squibb a risky company?

In a competitive pharmaceutical market, Bristol-Myers Squibb faces risks from patent expirations and the introduction of generic alternatives. Market analysts forecast a lower EPS of 0.93 for the current year, which may signal slower growth expectations moving forward. What is Bristol-Myers Squibb's forecast for 2025? ...